Search Results for: vaccine

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had its stock price fall by -17.2% per share on Thursday, June 9, 2022. (See past coverage if needed: “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021; By Kuldip K. Ambastha.”) In 1Q2022, earnings per share plus total …

Continue reading “What Caught Our Attention in the Investment World? – Week of June 6-10, 2022”

By Kuldip K. Ambastha Novavax, Inc. (NVAX), a clinical-stage vaccine company, had four negative daily returns and one positive daily return for its shares during this past trading week per the table displayed here. Worldwide, the coronavirus pandemic continues to be a serious public health issue, especially through the Delta and Omicron COVID-19 variants. Novavax …

Continue reading “What Caught Our Attention in the Investment World? – Week of December 27-31, 2021”

By Kuldip K. Ambastha BioNTech SE (BNTX) is aiming to become a leading biotechnology company with a main focus on individualized cancer medicine. The company has also been successful in offering an mRNA-based, two-shot coronavirus vaccine called BNT162b2 (aka: Comirnaty and Tozinameran), which has become increasingly important due to the rise of the highly contagious …

Continue reading “What Caught Our Attention in the Investment World? – Week of August 9-13, 2021”

By Kuldip K. Ambastha On Friday, July 16, 2021, the stock of Moderna, Inc. (MRNA) was up by +10.3% for the trading day. Moderna, a biotechnology company, has been highly successful in its efforts to develop a coronavirus (COVID-19) vaccine. Late on Thursday, July 15, 2021, S&P Dow Jones Indices announced that Moderna will become …

Continue reading “What Caught Our Attention in the Investment World? – Week of July 12-16, 2021”

By Kuldip K. Ambastha Carnival Corporation (CCL) is well-known as a cruise operator and as a prominent travel / leisure company. This British-American company has struggled recently due to the coronavirus pandemic seen worldwide. However, during this week, the company had strong days on Monday, April 6, 2020 and Tuesday, April 7, 2020, returning 20.3% …

Continue reading “What Caught Our Attention in the Investment World? – Week of April 6-10, 2020”

By Kuldip K. Ambastha The Dow Jones was up and down this week day by day, similar to what has been seen in the past few weeks. Due to the coronavirus pandemic and its related public health concerns around the world, massive changes have been seen in the USA and these changes have been affecting …

Continue reading “Jobs, Unemployment, and the Dow Jones – Week of March 30 – April 3, 2020”

By Kuldip K. Ambastha This past week was a volatile one in the investment markets, worldwide. “May you live in interesting times” was a quote popularized during the global financial crisis (GFC) era. This same quote applies now as well, in terms of the wild roller coaster ride seen for March 16-20. On a daily …

Continue reading “A Wild Roller Coaster Ride – Week of March 16-20, 2020”

By Kuldip K. Ambastha and Anil K. Ambastha On Tuesday, February 25, 2020, the stock of Moderna, Inc. (MRNA) rose by 27.8% for the day. As the coronavirus (COVID-19) has spread around the world and led to a sell-off in the capital markets, Moderna, Inc. announced that its coronavirus vaccine candidate is scheduled to be …

Continue reading “What Caught Our Attention in the Investment World? – Week of February 24-28, 2020”